Chelsea Therapeutics International Ltd. (CHTP) has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because CHTP is now in overbought territory with an RSI value of 71.85. Furthermore, estimates for the Chelsea Therapeutics have been coming down, pushing it to a Zacks Rank #4 (Sell). This suggests that investors may better off exiting this stock before it falls back to Earth.
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment